Contact Information: Inquiries Press Jon Coles Brunswick - London Tel: +44 (0) 20 7404 5959 Investors and Analysts Phil Cowdy +44 (0)20 7401 7646 Director - Investor Relations Smith & Nephew
Smith & Nephew Announces Portfolio Addition for Surgeons Managing Traumatic Injuries
| Source: Smith & Nephew PLC
LONDON--(Marketwire - December 23, 2009) - Smith & Nephew (NYSE : SNN ) (LSE : SN ) Advanced Wound
Management division, announces the agreement to partner with Gunze Limited,
Japan and exclusively distribute PELNAC dermal replacement in Japan, South
Africa, Australia and New Zealand. PELNAC is a collagen matrix with
silicone top layer for use on full thickness injuries such as burns and
trauma. It helps promote the regeneration of damaged dermal layers as an
alternative to using the patient's own dermis which may not be available
with extensive injuries. PELNAC will be available from Smith and Nephew in
Japan from January 1st, 2010, with South Africa and Australia following
shortly after.
"I am delighted that we can add PELNAC to our portfolio," said Leon Hoare,
President - Advanced Wound Management, Asia Pacific. "It provides a
solution to the needs of many plastic and burn surgeons who deal with
serious injuries and helps to support the patients with a good cosmetic
outcome."
"The addition of PELNAC enhances our wound care offering for burns and
trauma injuries," commented Roger Teasdale, President, Smith & Nephew Wound
Management. "We are very pleased to be working with Gunze and look forward
to the opportunities that lay ahead for both businesses."
For more information regarding Smith & Nephew, please visit our Web site at
http://www.smith-nephew.com
* Trademark of Smith & Nephew
™Trademark of Gunze Limited
Notes for Editors
About Smith & Nephew
Smith & Nephew is a global medical technology business, specializing in
Orthopaedics, including Reconstruction, Trauma and Clinical Therapies,
Endoscopy and Advanced Wound Management. Smith & Nephew is a global leader
in arthroscopy and advanced wound management and is one of the leading
global orthopaedics companies.
Smith & Nephew is dedicated to helping improve people's lives. The Company
prides itself on the strength of its relationships with its surgeons and
professional healthcare customers, with whom its name is synonymous with
high standards of performance, innovation and trust. The Company operates
in 32 countries around the world. Annual sales in 2008 were nearly $3.8
billion.
Forward-Looking Statements
This press release contains certain "forward-looking statements" within the
meaning of the US Private Securities Litigation Reform Act of 1995. In
particular, statements regarding expected revenue growth and trading
margins discussed under "Outlook" are forward-looking statements as are
discussions of our product pipeline. These statements, as well as the
phrases "aim", "plan", "intend", "anticipate", "well-placed", "believe",
"estimate", "expect", "target", "consider" and similar expressions, are
generally intended to identify forward-looking statements. Such
forward-looking statements involve known and unknown risks, uncertainties
and other important factors (including, but not limited to, the outcome of
litigation, claims and regulatory approvals) that could cause the actual
results, performance or achievements of Smith & Nephew, or industry
results, to differ materially from any future results, performance or
achievements expressed or implied by such forward-looking statements.
Please refer to the documents that Smith & Nephew has filed with the U.S.
Securities and Exchange Commission under the U.S. Securities Exchange Act
of 1934, as amended, including Smith & Nephew's most recent annual report
on Form 20F, for a discussion of certain of these factors.
All forward-looking statements in this press release are based on
information available to Smith & Nephew as of the date hereof. All written
or oral forward-looking statements attributable to Smith & Nephew or any
person acting on behalf of Smith & Nephew are expressly qualified in their
entirety by the foregoing. Smith & Nephew does not undertake any
obligation to update or revise any forward-looking statement contained
herein to reflect any change in Smith & Nephew's expectation with regard
thereto or any change in events, conditions or circumstances on which any
such statement is based.